Ark Genomic Revolution ETF (ARKG)
18.80 x 3 18.90 x 2
Pre-market by (Cboe BZX)
19.74 -1.13 (-5.41%) 04/03/25 [NYSE Arca]
18.80 x 3 18.90 x 2
Pre-market 18.80 -0.94 (-4.76%) 08:39 ET
for Fri, Apr 4th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ARKG | VHT | IBB | ||
| Company | Ark Genomic Revolution ETF | Healthcare ETF Vanguard | Nasdaq Biotechnology Ishares ETF | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NASDAQ | ||
| Open | 18.74 | 253.17 | 121.00 | ||
| High | 18.74 | 253.17 | 121.00 | ||
| Low | 18.74 | 253.17 | 121.00 | ||
| Last | 18.74 | 253.17 | 121.00 | ||
| Change | -1.00 | -5.92 | -2.79 | ||
| % Change | -5.07% | -2.28% | -2.25% | ||
| Volume | 166,187 | 1,228 | 4,677 | ||
| 20-Day Average Volume | 3,285,979 | 163,641 | 1,150,394 | ||
| Previous Close | 19.74 | 259.09 | 123.79 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.09 | 264.19 | 131.38 | ||
| 20-Day Raw Stochastic | 0.00% | 0.00% | 0.00% | ||
| 20-Day Relative Strength | 33.26% | 34.90% | 31.25% | ||
| Weighted Alpha | -36.55 | -6.45 | -14.61 | ||
| Today's Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 8% Sell | 8% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.04% since 03/28/25 | -3.70% since 03/28/25 | -7.13% since 03/28/25 | ||
| Low | 18.74 on 04/04/25 | 253.17 on 04/04/25 | 121.00 on 04/04/25 | ||
| High | 21.25 on 04/02/25 | 266.00 on 03/31/25 | 128.55 on 03/31/25 | ||
| 1-Month | |||||
| %Chg | -20.36% since 03/04/25 | -6.08% since 03/04/25 | -9.94% since 03/04/25 | ||
| Low | 18.74 on 04/04/25 | 253.17 on 04/04/25 | 121.00 on 04/04/25 | ||
| High | 24.18 on 03/24/25 | 273.34 on 03/07/25 | 138.29 on 03/07/25 | ||
| 3-Month | |||||
| %Chg | -27.02% since 01/03/25 | -1.33% since 01/03/25 | -9.80% since 01/03/25 | ||
| Low | 18.74 on 04/04/25 | 253.17 on 04/04/25 | 121.00 on 04/04/25 | ||
| High | 31.16 on 02/18/25 | 274.19 on 02/05/25 | 142.80 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | -24.62% since 10/04/24 | -8.87% since 10/04/24 | -15.91% since 10/04/24 | ||
| Low | 18.74 on 04/04/25 | 250.07 on 12/19/24 | 121.00 on 04/04/25 | ||
| High | 31.16 on 02/18/25 | 283.73 on 10/14/24 | 150.04 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 987,515 | 16,304,133 | 5,576,740 | ||
| Shares Outstanding, K | 47,300 | 62,199 | 45,050 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 1.50 | 0.73 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.382 on 12/29/21 | 0.940 on 03/25/25 | 0.121 on 03/18/25 | ||
| Next Ex-Dividends Date | 12/29/21 | 03/25/25 | 03/18/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.00 | 15.68 | ||